NextCure board sets Dec. 8 record date for contingent value rights distribution
NXTC•NextCure set Dec. 8, 2026, as the record date for a pre-closing distribution expected on Dec. 14, subject to the merger’s First Effective Time. Eligible common and preferred stockholders will receive one contingent value right per share, tied to 90% of gross proceeds from legacy-asset disposals, less permitted deductions.
1. Distribution details
NextCure’s board set Dec. 8, 2026, as the record date for its pre-closing distribution. The distribution is expected on Dec. 14, subject to the merger’s First Effective Time occurring. Eligible common and preferred stockholders will receive one contingent value right per share; the rights provide for 90% of gross proceeds from legacy-asset disposals during the CVR term, less permitted deductions.




